Nurse-Driven Intravenous Heparin Protocol Quality Improvement Initiative
Nurse-Driven Intravenous Heparin Protocol Quality Improvement Initiative
复制标题
DOI：
10.1097/nci.0b013e3181d2f2c6
复制
发表时间：
2010-04-01
影响因子：
2.2
通讯作者：
Watts, Brook
中科院分区：
文献类型：
--
作者：
Williams, Tanya D.;Sullivan, Katherine;Watts, Brook
背景：安全使用静脉肝素是一个重要的安全目标。目的：提高静脉肝素的使用质量。研究方法：干预前后设计评估了达到治疗性活化部分凝血活酶时间（aPTT）的患者数量、达到aPTT目标的时间和并发症。50例传统护理患者与50例护士驱动的静脉肝素方案患者进行了比较。这些数据用于评估开发的干预包的有效性，以提高静脉肝素使用的质量。结果：干预前组中有16%的患者从未达到治疗目标，而干预后组中有8%的患者从未达到治疗目标（P
Background: Safe use of intravenous heparin is an important safety goal. Objective: To improve the quality of intravenous heparin use. Methods: A pre-post intervention design assessed the number of patients who reached a therapeutic activated partial thromboplastin time (aPTT), time to aPTT goal, and complications. Fifty traditional care patients were compared with 50 nurse-driven intravenous heparin protocol patients. The data were used to assess the effectiveness of a developed intervention package to improve the quality of intravenous heparin use. Results: Sixteen percent of the preintervention group never reached the therapeutic goal compared with 8% in the postintervention group (P